HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice.

AbstractBACKGROUND AND PURPOSE:
The fibronectin isoform containing the alternatively spliced extra domain A (EDA(+)-FN) is normally absent from the circulation, but plasma levels of EDA(+)-FN can become markedly elevated in several human pathological conditions associated with inflammation including ischemic stroke. It remains unknown whether EDA(+)-FN contributes to stroke pathogenesis or is simply an associative marker. Several in vitro studies suggest that EDA(+)-FN can activate Toll-like receptor 4, an innate immune receptor that triggers proinflammatory responses. We undertook a genetic approach in mice to investigate the ability of EDA(+)-FN to mediate inflammatory brain damage in a focal cerebral ischemia/reperfusion injury model.
METHODS:
We used genetically modified EDA(+/+) mice, which constitutively express EDA(+)-FN. Extent of injury, neurological outcome, and inflammatory mechanisms were assessed after 1-hour cerebral ischemia/23-hour reperfusion injury and compared with wild-type mice.
RESULTS:
We found that EDA(+/+) mice developed significantly larger infarcts and severe neurological deficits that were associated with significant increased neutrophil and macrophage infiltration as quantitated by immunohistochemistry. Additionally, we found upregulation of nuclear factor-κB, cyclo-oxygenase-2, and inflammatory cytokines tumor necrosis factor-α, interleukin-1β, and interleukin-6 in the EDA(+/+) mice compared with wild-type mice. Interestingly, increased brain injury and neurological deficits were largely abrogated in EDA(+/+) mice by treatment with a specific Toll-like receptor 4 inhibitor.
CONCLUSIONS:
These findings provide the first evidence that EDA(+)-FN promotes inflammatory brain injury after ischemic stroke and suggest that the elevated levels of plasma EDA(+)-FN observed in chronic inflammatory conditions could worsen injury and outcome in patients after acute stroke.
AuthorsMohammad Moshahid Khan, Chintan Gandhi, Neelam Chauhan, Jeff W Stevens, David G Motto, Steven R Lentz, Anil K Chauhan
JournalStroke (Stroke) Vol. 43 Issue 5 Pg. 1376-82 (May 2012) ISSN: 1524-4628 [Electronic] United States
PMID22363055 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cytokines
  • Fibronectins
  • NF-kappa B
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • extra domain A fibronectin, mouse
  • Cyclooxygenase 2
Topics
  • Alternative Splicing (genetics)
  • Animals
  • Brain Injuries (blood, etiology, physiopathology)
  • Brain Ischemia (blood, complications, physiopathology)
  • Cyclooxygenase 2 (physiology)
  • Cytokines (physiology)
  • Encephalitis (blood, etiology, physiopathology)
  • Fibronectins (blood, genetics, physiology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Models, Animal
  • NF-kappa B (physiology)
  • Protein Structure, Tertiary (genetics)
  • Time Factors
  • Toll-Like Receptor 4 (physiology)
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: